Teva Strikes Two Major Deals For Eculizumab And Aflibercept Biosimilars

Samsung And Formycon Supply US Soliris And European Eylea Rivals

 
• By Dave Wallace
  
Teva has struck a pair of biosimilars deals in the US and Europe (Shutterstock)

More from Deals

More from Products